The observed higher prevalence of TP53 mutations in cancer subjects reported in this study is consistent with previously reported greater somatic cell genetic damage in histologically normal airway epithelium of lung cancer cases compared to controls matched for smoking and age [7–9]. The gene discussed is TP53; the disease is lung carcinoma.